Table 2 Perioperative variables of the matched groups
Intra-arterial | No Intra-arterial | p value | |
|---|---|---|---|
Patients (n) | 26 | 78 | |
Type of urinary diversion, n (%) | 0.840 | ||
Cutaneous ureterostomy | 2(7.7%) | 5(6.4%) | |
Ileal conduit | 9(34.6%) | 32(41.0%) | |
Orthotopic neobladder | 15(57.7%) | 41(52.6%) | |
Operating time, min, mean (IQR) | 369.0(300.0–420.0) | 382.9(306.0–420.0) | 0.574 |
Estimated blood loss, ml, mean (IQR) | 411.5(187.5–525.0) | 348.1(200.0–400.0) | 0.456 |
Removed Jackson-Pratt drain, day, mean (IQR) | 12.6(9.0–14.3) | 14.7(8.0–19.0) | 0.591 |
Passing flatus, day, mean (IQR) | 4.9(3.0–6.0) | 4.0(3.0–5.0) | 0.189 |
Adjuvant chemotherapy, n (%) | 4(15.4%) | 12(15.4%) | 1.000 |
Pre-op laboratory studies | |||
HGB (g/L), median (IQR) | 134.0(122.3–142.3) | 132.5(119.8–146.3) | 0.943 |
HCT (%), median (IQR) | 38.6(36.9–41.5) | 39.8(36.1–42.4) | 0.615 |
WBC, median (IQR) | 6.4(5.0–7.6) | 6.5(5.3–7.8) | 0.286 |
Platelets, median (IQR) | 218.5(193.0–262.5) | 216.5(187.3–258.5) | 0.768 |
BUN(mmol/L), median (IQR) | 5.7(4.7–7.0) | 6.1(4.6–8.0) | 0.119 |
Creatinine(μmol/L), median (IQR) | 84.2(70.3–113.5) | 82.2(70.1–99.9) | 0.702 |
Albumin (g/L), median (IQR) | 35.1(32.8–39.0) | 36.0(33.0–39.9) | 0.931 |
Overall complications, n (%), Clavien grade | 24(92.3%) | 75(96.2%) | 0.791 |
Perioperative complications (< 30 d), n (%), | 0.930 | ||
0 | 2(7.7%) | 3(3.8%) | |
1 | 0(0.0%) | 2(2.6%) | |
2 | 21(80.8%) | 66(84.6%) | |
3 | 3(11.5%) | 5(6.4%) | |
4 | 0(0.0%) | 0(0.0%) | |
Short-term complications (< 90 d), n (%) | 0.516 | ||
0 | 24(92.3%) | 68(87.2%) | |
1 | 0(0.0%) | 4(5.1%) | |
2 | 1(3.8%) | 3(3.8%) | |
3 | 1(3.8%) | 3(3.8%) | |
4 | 0(0.0%) | 0(0.0%) | |
Long-term complications (>90 d), n (%) | 0.616 | ||
0 | 24(92.3%) | 74(94.9%) | |
1 | 0(0.0%) | 0(0.0%) | |
2 | 0(0.0%) | 0(0.0%) | |
3 | 1(3.8%) | 3(3.8%) | |
4 | 1(3.8%) | 1(1.3%) | |
Surgery intensive care unit stay, n (%) | 0(0.0%) | 8(10.3%) | 0.196 |